Skip to content
Avania

Avania

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Avania?

Avania is a French MedTech company, currently owned by Omnes Capital since 2022 and Astorg. It changed hands in 2022, when Kester Capital sold.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Astorg
Most recent investor
Astorg
Astorg Mid-Cap · 2022 · Buyout
3 ownership periods · full history below

Key facts

HQFrance
SectorMedTech
Key takeaways
  • ·Co-held by Omnes Capital and Astorg since 2022.
  • ·Best return: 8.0x MOIC by Kester Capital (2022 exit).

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Omnes Capital and Astorg since 2022.
Kester Capital
Kester CapitalExited 2022
2016 · 2022(6yr) · Kester Capital II · 2019 · Small-Mid Buyout
Secondary · to Astorg

Kester Capital sold Avania to Astorg in 2022 after 6 years.

MOIC
8.0x
Co-invest · 2 holders · 2022 · present
Omnes Capital
2022 · present(4yr) · Omnes Co-Investment · 2008 · Buyout
Astorg
AstorgActive
2022 · present(4yr) · Astorg Mid-Cap · 2022 · Buyout

Questions

Who owns Avania?

Avania is currently owned by Omnes Capital and Astorg, through Astorg Mid-Cap, since 2022.

When did Omnes Capital and 1 other acquire Avania?

Omnes Capital and 1 other acquired Avania in 2022.

Who did Avania sell to?

Kester Capital sold Avania to Astorg in 2022 (Secondary), 8.0x return.

Who has owned Avania over time?

Avania has been through 3 private-equity ownership periods: Kester Capital · via Kester Capital II · 2016–2022 · sold to Astorg · (Secondary) · 8.0x; Omnes Capital · via Omnes Co-Investment · since 2022; Astorg · via Astorg Mid-Cap · since 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue